Gilmore O’Neill

Company: Editas Medicine

Job title: President & Chief Executive Officer

Seminars:

Industry leader’s Fireside Chat: Navigating the Path to the Clinic to Accelerate Clinical Efficacy 8:40 am

Discussing preclinical development best practices to supercharge preclinical approval Discussing translational and IND approval challenges Highlighting clinical successesRead more

day: Day One

Exploring the Possibilities of In Vivo Gene Editing to Diversify Treatment Opportunities 3:15 pm

Exploring how in vivo genetic editing could unlock treatments for previously untreatable genetic disorders and complex diseases Understanding how advances in genetic editing will enable more tailored, patient-specific therapies for improved outcomes Discuss the hurdles of ensuring sustained effects and safety of in vivo genetic editing therapies over timeRead more

day: Day Two